Literature DB >> 9867228

Effects of MK-801 on vicarious trial-and-error and reversal of olfactory discrimination learning in weanling rats.

G S Griesbach1, D Hu, A Amsel.   

Abstract

The effects of dizocilpine maleate (MK-801) on vicarious trial-and-error (VTE), and on simultaneous olfactory discrimination learning and its reversal, were observed in weanling rats. The term VTE was used by Tolman (The determiners of behavior at a choice point. Psychol. Rev. 1938;46:318-336), who described it as conflict-like behavior at a choice-point in simultaneous discrimination learning. It takes the form of head movements from one stimulus to the other, and has recently been proposed by Amsel (Hippocampal function in the rat: cognitive mapping or vicarious trial-and-error? Hippocampus, 1993;3:251-256) as related to hippocampal, nonspatial function during this learning. Weanling male rats received systemic MK-801 either 30 min before the onset of olfactory discrimination training and its reversal, or only before its reversal. The MK-801-treated animals needed significantly more sessions to acquire the discrimination and showed significantly fewer VTEs in the acquisition phase of learning. Impaired reversal learning was shown only when MK-801 was administered during the reversal-learning phase, itself, and not when it was administered throughout both phases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9867228     DOI: 10.1016/s0166-4328(98)00015-1

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  11 in total

1.  NMDA receptor antagonism impairs reversal learning in developing rats.

Authors:  Kathryn K Chadman; Deborah J Watson; Mark E Stanton
Journal:  Behav Neurosci       Date:  2006-10       Impact factor: 1.912

2.  NMDA receptor in conditioned flavor-taste preference learning: blockade by MK-801 and enhancement by D-cycloserine.

Authors:  Glen J Golden; Thomas A Houpt
Journal:  Pharmacol Biochem Behav       Date:  2007-02-09       Impact factor: 3.533

3.  The ventral midline thalamus coordinates prefrontal-hippocampal neural synchrony during vicarious trial and error.

Authors:  John J Stout; Henry L Hallock; Allison E George; Suhaas S Adiraju; Amy L Griffin
Journal:  Sci Rep       Date:  2022-06-29       Impact factor: 4.996

4.  NMDA receptor involvement in spatial delayed alternation in developing rats.

Authors:  Deborah J Watson; Mariel R Herbert; Mark E Stanton
Journal:  Behav Neurosci       Date:  2009-02       Impact factor: 1.912

5.  T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions.

Authors:  Jonathan Kipnis; Hagit Cohen; Michal Cardon; Yaniv Ziv; Michal Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-12       Impact factor: 11.205

6.  Medial prefrontal administration of MK-801 impairs T-maze discrimination reversal learning in weanling rats.

Authors:  Deborah J Watson; Mark E Stanton
Journal:  Behav Brain Res       Date:  2009-07-28       Impact factor: 3.332

7.  Factors governing single-trial contextual fear conditioning in the weanling rat.

Authors:  M A Burman; N J Murawski; F L Schiffino; J B Rosen; M E Stanton
Journal:  Behav Neurosci       Date:  2009-10       Impact factor: 1.912

8.  Intrahippocampal administration of an NMDA-receptor antagonist impairs spatial discrimination reversal learning in weanling rats.

Authors:  Deborah J Watson; Mark E Stanton
Journal:  Neurobiol Learn Mem       Date:  2009-02-25       Impact factor: 2.877

9.  Aging impairs deliberation and behavioral flexibility in inter-temporal choice.

Authors:  Yannick-André Breton; Kelsey D Seeland; A David Redish
Journal:  Front Aging Neurosci       Date:  2015-03-27       Impact factor: 5.750

10.  The neural substrates of deliberative decision making: contrasting effects of hippocampus lesions on performance and vicarious trial-and-error behavior in a spatial memory task and a visual discrimination task.

Authors:  David Bett; Elizabeth Allison; Lauren H Murdoch; Karola Kaefer; Emma R Wood; Paul A Dudchenko
Journal:  Front Behav Neurosci       Date:  2012-10-30       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.